Choi notes that many of these lifestyle changes will not only reduce uric acid levels and the risk of recurrent gout but will also improve the health status of those with comorbidities ...

Japanese drugmaker Eisai (TYO: 4523) today announced that it has received approval for Urece (dotinurad) from the National Medical Products Administration (NMPA) in China as a treatment for gout ...

Aaa A Aa Aaaaaa 11.340 +21.49% ...

TOKYO, Jan 22, 2025 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been listed in the 2025 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by ...

Methods: In this prospective study, patients with gout receiving urate lowering therapy with benzbromarone were assigned to two groups, a renal underexcretion and an unclassified type. The primary ...